Hourly Market Review - Feb 27, 2024 14 PM

Generated by AI AgentMarket Brief
Tuesday, Feb 27, 2024 2:00 pm ET1min read

The Dow Jones Industrial Average declined by 140 points, or 0.4%, as the market rally paused, with investors awaiting key inflation data. The S&P 500 was slightly lower, while the Nasdaq Composite rose by 0.2%. Macy's shares increased by over 2% after announcing the closure of around 150 stores due to a revenue miss in the previous quarter. Lowe's shares rose 2.4% following an earnings beat. Zoom Video and Hims & Hers Health saw significant gains of 6.4% and 31.5%, respectively, after exceeding Wall Street expectations in their earnings reports.

Movers of the hour:

Janux Therapeutics is up 210.00% at $46.81.  

Viking Therapeutics is up 110.69% at $81.16.  

Solarmax Technology is up 72.00% at $6.88.  

Gaotu Techedu is up 36.18% at $8.09.  

Turnstone Biologics is up 34.91% at $5.41.  

Here are the top stocks upgraded by Wall Street analyst:

Berkshire Hathaway A has received a rating of Neutral from Keefe, Bruyette & Woods with target price increased to $645000 from $610000.

Broadcom has received a rating of Strong Buy from UBS with target price increased to $1480 from $1475.

Walmart has received a rating of Buy from Morgan Stanley with target price dropped to $67 from $200.

The Home Depot has received a rating of Neutral from RBC Capital with target price increased to $377 from $299.

Salesforce has received a rating of Neutral from Citigroup with target price increased to $325 from $265.

Arm Holdings has received a rating of Strong Buy from Rosenblatt with target price increased to $180 from $140.

Booking Holdings has received a rating of Strong Buy from Susquehanna with target price increased to $4100 from $3600.

Sony Group has received a rating of Buy from Oppenheimer with target price increased to $108 from $108.

Palo Alto Networks has received a rating of Strong Buy from Susquehanna with target price dropped to $325 from $400.

Comments



Add a public comment...
No comments

No comments yet